CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany

MONMOUTH JUNCTION, N.J., May 2, 2022 -- (Healthcare Sales & Marketing Network) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, an... Devices, Group Purchasing CytoSorbents, CytoSorb, blood purification
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news